Jet Airways Shares Surge As Naresh Goyal Steps Down From Board
Jet Airways shares surged as much as 17.77 per cent to an intraday hit high of Rs 266 on the BSE as the airline announced that its founder Naresh Goyal and his wife Anita Goyal stepped down from board of directors. The exit of Naresh Goyal and Anita Goyal, from the board of the airline they founded 25 years ago, came as part of the resolution plan to rescue the debt-laden Jet Airways from falling into bankruptcy. The group of lenders, led by State Bank of India, will also convert their debt into equity by acquiring 11.4 crore equity shares at 1 rupee per share, Jet Airways said in a regulatory filing post-market hours.
As part of the resolution plan, lenders will provide an immediate funding support of Rs 1,500 crore by way of debt instrument against security of its assets which will restore normalcy to company's level of operations, the filing added.
Meanwhile, Jet Airways said it constituted an Interim Management Committee to monitor its daily operations and cash flow.
Kevin Knight, nominee of Etihad Airways PJSC, also resigned as director from the airline's board, Jet Airways noted.
Saddled with more than $1 billion of debt, Jet is struggling to stay afloat. Jet owes money to banks, suppliers, pilots and lessors - several of whom have started terminating leases with the carrier.
In Monday's trading session, Jet Airways shares ended 12.69 per cent higher at Rs 254.50 on the BSE. The stock outperformed the S&P BSE Sensex which closed 0.9 per cent lower. On the National Stock Exchange, the stock rose 15.46 per cent to close at Rs 261.
The stock saw heightened trading volume. As many as 33.60 lakh shares changed hands on the BSE compared with an average of 9.40 lakh shares traded daily in the past two weeks.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.